Phosphate diabetes in patients with chronic fatigue syndrome.
Abstract
Phosphate depletion is associated with neuromuscular dysfunction due to changes in mitochondrial respiration that result in a defect of intracellular oxidative metabolism. Phosphate diabetes causes phosphate depletion due to abnormal renal re-absorption of phosphate be the proximal renal tubule. Most of the symptoms presented by patients with phosphate diabetes such as myalgia, fatigue and mild depression, are also common in patients with chronic fatigue syndrome, but this differential diagnosis has not been considered. We investigated the possible association between chronic fatigue syndrome and phosphate diabetes in 87 patients who fulfilled the criteria for chronic fatigue syndrome. Control subjects were 37 volunteers, who explicitly denied fatigue and chronic illness on a screening questionnaire. Re-absorption of phosphate by the proximal renal tubule, phosphate clearance and renal threshold phosphate concentration were the main outcome measures in both groups. Of the 87 patients with chronic fatigue syndrome, nine also fulfilled the diagnostic criteria for phosphate diabetes. In conclusion, we report a previously undefined relationship between chronic fatigue syndrome and phosphate diabetes. Phosphate diabetes should be considered in differential diagnosis with chronic fatigue syndrome; further studies are needed to investigate the incidence of phosphate diabetes in patients with chronic fatigue syndrome and the possible beneficial effect of vitamin D and oral phosphate supplements.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (700K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Straus SE, Jones JF, Dubois RE, Cunningham-Rundles C, Pahwa S, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med. 1988 Mar;108(3):387–389. [PubMed] [Google Scholar]
- McKenzie R, Straus SE. Chronic fatigue syndrome. Adv Intern Med. 1995;40:119–153. [PubMed] [Google Scholar]
- Lundberg E, Bergengren H, Lindqvist B. Mild phosphate diabetes in adults. Acta Med Scand. 1978;204(1-2):93–96. [PubMed] [Google Scholar]
- Laroche M, Arlet J, Ader JL, Durand D, Tran-Van T, Mazières B. Skeletal manifestations of moderate phosphate diabetes. Clin Rheumatol. 1993 Jun;12(2):192–197. [PubMed] [Google Scholar]
- Walton RJ, Bijvoet OL. Nomogram for derivation of renal threshold phosphate concentration. Lancet. 1975 Aug 16;2(7929):309–310. [PubMed] [Google Scholar]
- Wong R, Lopaschuk G, Zhu G, Walker D, Catellier D, Burton D, Teo K, Collins-Nakai R, Montague T. Skeletal muscle metabolism in the chronic fatigue syndrome. In vivo assessment by 31P nuclear magnetic resonance spectroscopy. Chest. 1992 Dec;102(6):1716–1722. [PubMed] [Google Scholar]
- Stoff JS. Phosphate homeostasis and hypophosphatemia. Am J Med. 1982 Mar;72(3):489–495. [PubMed] [Google Scholar]
- Knochel JP. Neuromuscular manifestations of electrolyte disorders. Am J Med. 1982 Mar;72(3):521–535. [PubMed] [Google Scholar]
- Barnes PR, Taylor DJ, Kemp GJ, Radda GK. Skeletal muscle bioenergetics in the chronic fatigue syndrome. J Neurol Neurosurg Psychiatry. 1993 Jun;56(6):679–683. [PMC free article] [PubMed] [Google Scholar]
- Brautbar N, Carpenter C, Baczynski R, Kohan R, Massry SG. Impaired energy metabolism in skeletal muscle during phosphate depletion. Kidney Int. 1983 Jul;24(1):53–57. [PubMed] [Google Scholar]
- Kemp GJ. Abnormalities of Pi concentration in plasma and in cells. Clin Chem. 1993 Sep;39(9):2028–2031. [PubMed] [Google Scholar]
- Thompson CH, Kemp GJ. Reduced muscle cell phosphate (Pi) without hypophosphatemia in mild dietary Pi deprivation. Clin Chem. 1995 Jun;41(6 Pt 1):946–947. [PubMed] [Google Scholar]
- Amor B, Clemente-Coelho PJ, Roux C. Adult-onset idiopathic phosphate diabetes. II. Time-course of clinical, laboratory test, and bone mineral density abnormalities under combined phosphate and calcitriol therapy. Rev Rhum Engl Ed. 1995 Mar;62(3):183–188. [PubMed] [Google Scholar]
- Wilson JR, Fink L, Maris J, Ferraro N, Power-Vanwart J, Eleff S, Chance B. Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance. Circulation. 1985 Jan;71(1):57–62. [PubMed] [Google Scholar]
- Dawson MJ, Gadian DG, Wilkie DR. Muscular fatigue investigated by phosphorus nuclear magnetic resonance. Nature. 1978 Aug 31;274(5674):861–866. [PubMed] [Google Scholar]
- Sahlin K, Henriksson J. Buffer capacity and lactate accumulation in skeletal muscle of trained and untrained men. Acta Physiol Scand. 1984 Nov;122(3):331–339. [PubMed] [Google Scholar]
- Wilson JR, McCully KK, Mancini DM, Boden B, Chance B. Relationship of muscular fatigue to pH and diprotonated Pi in humans: a 31P-NMR study. J Appl Physiol (1985) 1988 Jun;64(6):2333–2339. [PubMed] [Google Scholar]
- Demitrack MA, Engleberg NC. Chronic fatigue syndrome. Curr Ther Endocrinol Metab. 1994;5:135–142. [PubMed] [Google Scholar]
- Land JM, Kemp GJ, Taylor DJ, Standing SJ, Radda GK, Rajagopalan B. Oral phosphate supplements reverse skeletal muscle abnormalities in a case of chronic fatigue with idiopathic renal hypophosphatemia. Neuromuscul Disord. 1993 May;3(3):223–225. [PubMed] [Google Scholar]
- Hodgson SF, Hurley DL. Acquired hypophosphatemia. Endocrinol Metab Clin North Am. 1993 Jun;22(2):397–409. [PubMed] [Google Scholar]
- Constantin A, Laroche M, Moulinier L, Bon E, Ramonjisoa M, Cantagrel A, Mazieres B. Tubular excretion of phosphate in Paget's disease of bone. Effect of pamidronate. Rev Rhum Engl Ed. 1995 Jul-Sep;62(7-8):493–500. [PubMed] [Google Scholar]
